|

Temple Health Chest Initiative (THCI 2.0)

RECRUITINGSponsored by Temple University
Actively Recruiting
SponsorTemple University
Started2025-02-28
Est. completion2026-05-31
Eligibility
Age50 Years – 80 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06933758

Summary

Chronic obstructive pulmonary disease is highly prevalent globally, with considerable morbidity and mortality associated. In the US, it is the 4th leading cause of death, as well as contributing to significant costs on healthcare utilization including hospitalization. Population-based screening for COPD has not been recommended by the US Preventative Services Task Force (USPSTF). However, LDCT screening for lung cancer in patients aged 50- 80 with ≥ 20 pack year smoking has been shown to improve survival. COPD is highly prevalent within LCS programs, with estimated rates of obstructive lung function of up to 59% and evidence of emphysema on CT scan in around 70%.

Eligibility

Age: 50 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* 50 to 80 years old
* Screened for early lung cancer using low dose CT imaging

Exclusion Criteria:

* Under 50; over 80 years old
* No lung cancer screening

Conditions4

COPDCancerChronic Obstructive Pulmonary Disease (COPD)Lung Cancer

Locations1 site

Temple University Of the Commonwealth System of Higher Education
Philadelphia, Pennsylvania, 19140
Lauren Miller, BS215-707-4821lauren.e.miller@temple.edu

Browse More Trials

Cancer trialsLung Cancer trialsCOPD trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.